Stephen G. Stroud

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index1.2kcitations34works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Microtubule and mitosis dynamics(18), Cancer-related Molecular Pathways(5), Speech and Audio Processing(4), Chemical Synthesis and Reactions(3), Oxidative Organic Chemistry Reactions(3)

Publications34 total

Advancing Audio Surveillance in Simulated Environments: Real-World Soundscapes and Targeted Noise Detection through Enhanced Beamforming Techniques
Journal of Advances in Engineering and Technology·2025Open Access
Developing Audio Zoom in Virtual Environments: Real-World Soundscapes and Targeted Noise Detection
2024Open Access
Enhancing Environmental Sound Recognition in Digital Simulations: A Novel Approach to Beamforming and Signal Identification
2024Open Access
Robust Audio Zoom for Surveillance Systems: A Beamforming Approach with Reduced Microphone Array
2023· 5 cited
Supplementary Figure 3 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Supplementary Figure 4 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Supplementary Figure 3 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Supplementary Figure 4 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Supplementary Figure Legends 1-4 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Data from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Data from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Supplementary Figure 2 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Supplementary Figure Legends 1-4 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Supplementary Figure 2 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Supplementary Figure 1 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Supplementary Figure 1 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
2023Open Access
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237)
Nuclear Medicine and Biology·2015· 10 cited
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
ACS Medicinal Chemistry Letters·2015· 108 citedOpen Access
Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)
Journal of Medicinal Chemistry·2011· 54 citedOpen Access
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays
Clinical Cancer Research·2011· 298 cited
page 1 of 2Next →

Frequent Co-authors

Christopher F. Claiborne(18), Todd B. Sells(17), Mark Manfredi(16), Jeffrey Ecsedy(16), Kara M. Hoar(16), Jessica J. Huck(16), Patrick Leroy(16), Deborah R. Wysong(16), Mengkun Zhang(16), David A. Janowick(16), Joseph B. Bolen(15), Wei Chen(14), Lee Silverman(14), Marc L. Hyer(14), Rachel E. Gershman(14), Arijit Chakravarty(13), Matthew D. Silva(13), Melissa S. Germanos(13), Vaishali Shinde(12), Tricia J. Vos(5)